RSPT: Why This Equal-Weight Tech Consolidation Is More Than Buyable

Invesco S&P 500 Equal Weight Technology ETF (RSPT) is rated a buy after delivering 41% YTD returns and outperforming cap-weighted technology indices. The ETF trades at a 19.7x P/E with projected long-term EPS growth of 17.06% and a PEG ratio just above 1.0x, supporting a favorable valuation case. Its diversified small- and mid-cap technology exposure reduces mega-cap concentration risk while positioning investors for capex-led sector tailwinds.

Analysis

The relevant exposure is RSPT, not IVZ: ETF-management economics are unlikely to move Invesco’s earnings unless the product attracts sustained, multi-billion-dollar net inflows. For IVZ, the actionable variable is therefore monthly flow momentum across its smart-beta and sector ETF complex rather than relative performance of a single fund. A short-term performance chase into RSPT could modestly support fee-related AUM, but it is not sufficient evidence for an IVZ rerating without confirmation in organic net flows and fee-rate retention.

RSPT’s equal-weight construction is effectively a systematic rotation away from the largest technology winners into smaller constituents. That is attractive if AI-related capex broadens into enterprise software, IT services, networking, and semiconductor equipment over the next 1-3 quarters; it is vulnerable if earnings revisions remain concentrated in mega-cap platforms and leading GPU suppliers. The key second-order risk is rebalancing drag: continued dispersion in which a handful of large names compound while the median technology company misses estimates can leave equal weight structurally behind cap-weighted technology despite apparently lower concentration risk.

Consensus appears to treat lower valuation as a free option on broadening. It is not: lower multiples may reflect lower margins, weaker recurring revenue, greater cyclicality, and more financing sensitivity among smaller technology constituents. A durable broadening thesis requires upward revisions to median constituent EPS and improving software/IT-spending indicators, not simply a valuation comparison. Over a 6-18 month horizon, falling rates and improving corporate IT budgets would favor RSPT; renewed long-duration multiple compression or a capex slowdown would favor XLK/QQQ leadership and pressure the equal-weight relative trade.

Key Decisions for Investors

• Do not initiate a directional IVZ position solely on this signal. Set an alert for two consecutive months of positive net flows into RSPT and broader Invesco equity ETFs; absent that confirmation, the product-level performance impact on IVZ earnings is likely immaterial.
• For a 1-3 month technology-breadth expression, consider long RSPT / short XLK in equal dollar amounts only after the RSPT-to-XLK relative ratio breaks above its 50-day moving average and median technology earnings revisions turn positive. Target 5-8% relative upside; exit if mega-cap earnings revisions reaccelerate while median revisions remain negative.
• For portfolios already overweight mega-cap AI beneficiaries, use a modest RSPT allocation as diversification rather than a replacement: cap the position at 25-35% of existing cap-weighted tech exposure until evidence of broadening appears in enterprise software bookings and IT-services guidance.
• Prefer XLK or QQQ over RSPT if the next earnings cycle shows continued concentration of revenue and free-cash-flow upgrades in hyperscalers and semiconductor leaders. That outcome falsifies the breadth thesis and can drive another 5-10% of relative underperformance for equal weight over a quarter.